|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09887 LEADS BIOLABS-B
Nominal 
66.900 0.000 (0.000%) Non-current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 29,758 | -18.198% | 36,378 | 54,282 |
| Land & other Lease Assets | 19,082 | 70.542% | 11,189 | 6,812 |
| Intangible Assets | 556 | -- | 0 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 30,941 | 21.010% | 25,569 | 19,267 |
| 80,337 | 9.846% | 73,136 | 80,361 | |
Current Assets
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Inventories | 30,811 | -- | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | |
| Cash & Bank Balances | 421,690 | 13.193% | 372,542 | 247,523 | |
| Other Current Assets | 97,795 | -56.296% | 223,765 | 119,598 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 550,296 | -7.716% | 596,307 | 367,121 | ||
Current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||
| Trade Payables | 962 | -72.701% | 3,524 | 215 | ||
| S-T Debt & Leases | 287,533 | 10.196% | 260,928 | 65,311 | ||
| Other Current Liabilities | 225,024 | 68.074% | 133,884 | 1,328,984 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 513,519 | 28.916% | 398,336 | 1,394,510 | |||
| Net Current Assets | 36,777 | -81.423% | 197,971 | (1,027,389) | ||
| Total Assets Less Current Liabilities | 117,114 | -56.802% | 271,107 | (947,028) | ||
Non-current Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||||
| L-T Debt & Leases | 12,025 | 116.784% | 5,547 | 1,777 | |||
| Other Non-current Liabilities | 218 | -- | 0 | 0 | |||
| 12,243 | 120.714% | 5,547 | 1,777 | ||||
Capital and Reserves
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||||
| Share Capital | 156,500 | 0.000% | 156,500 | 17,018 | ||||
| Reserves | (51,629) | -- | 109,060 | (965,823) | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 104,871 | -60.509% | 265,560 | (948,805) | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 104,871 | -60.509% | 265,560 | (948,805) | |||||
Commitments and Contingent Liabilities
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Commitments | -- | -- | 143 | 1,057 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 18/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -166,393 |
| %Change | -7.764% |
| EPS / (LPS) | RMB -1.060 |
| NBV Per Share (¥) | RMB -- |